HELP
Cybin Inc. Common Stock
NYSE MKT: HELP · HEALTHCARE · BIOTECHNOLOGY
$5.31
+8.15% today
Updated 2026-04-30
Market cap
$269.43M
P/E ratio
—
P/S ratio
16,436.36x
EPS (TTM)
$-4.30
Dividend yield
—
52W range
$4 – $10
Volume
1.3M
WallStSmart proprietary scores
30
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$44.01
+728.81%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-44.36M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-67.63M | $-47.49M | $-78.08M | $-113.14M | $-58.55M |
| EPS | — | — | — | — | $-4.30 |
| Free cash flow | $-45.73M | $-50.74M | $-69.62M | $-103.27M | $-44.36M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Cybin Inc. Common Stock trades at $5.31. Our Smart Value Score of 30/100 indicates the stock is weak.
Frequently asked questions
What is Cybin Inc. Common Stock's stock price?
Cybin Inc. Common Stock (HELP) trades at $5.31.
Is Cybin Inc. Common Stock overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Cybin Inc. Common Stock (HELP)?
The analyst target price is $44.01, representing +728.8% upside from the current price of $5.31.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio16,436.36x
ROE-55.90%
Beta1.04
50D MA$5.69
200D MA$6.51
Shares out0.05B
Float0.09B
Short ratio—
Avg volume1.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—